Perspectives on Genetically Engineered Microorganisms and Their Regulation in the United States.

Area of Science:

• Biotechnology and Genetic Engineering
• Regulatory Science
• Microbial Technology

Background:

• Genetically engineered microorganisms (GEMs) offer solutions across agriculture, manufacturing, and environmental remediation.
• Rapid advancements in genome-manipulating technologies are driving a surge in GEM-derived products.
• Existing U.S. biotechnology regulations struggle to keep pace with scientific progress.

Purpose of the Study:

• To analyze the interaction between U.S. regulatory policy and the development of GEMs.
• To bridge the gap between scientific innovation and regulatory frameworks.
• To provide perspectives from both regulators and developers on navigating biotechnology policy.

Main Methods:

• Analysis of regulatory policies governing biotechnology in the United States.
• Insights gathered from a 2022 workshop at UC Berkeley involving regulators and industry developers.
• Review of new biotechnologies and their assessment under current regulatory frameworks.

Main Results:

• Multiple U.S. agencies regulate biotechnology, creating overlapping responsibilities and challenges.
• Current policies face difficulties in balancing innovation with public and environmental safety.
• Recent regulatory updates aim to incorporate new technologies, but further adaptation is needed.

Conclusions:

• Effective regulation of GEMs requires continuous adaptation to scientific advancements.
• Collaboration between developers and regulators is crucial for fostering innovation while ensuring safety.
• Future regulatory strategies must be agile to accommodate emerging biotechnologies and applications.